Clinical Trial Update: Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution Capacities

View source ↗

Summary

A completed clinical trial evaluated serologic markers in inflammatory bowel disease across different clinical forms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Inflammatory Bowel Diseases | Status: COMPLETED